| 1 |
32103062 | In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson's Disease in Common Marmosets. | 2020 Feb 26 |
2 |
| 2 |
28420983 | Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson's Disease-Associated LRRK2 Gene Mutations. | 2017 |
1 |
| 3 |
26435084 | Bcl-xL-mediated antioxidant function abrogates the disruption of mitochondrial dynamics induced by LRRK2 inhibition. | 2016 Jan |
2 |
| 4 |
27394417 | Neuroprotective Effect of the LRRK2 Kinase Inhibitor PF-06447475 in Human Nerve-Like Differentiated Cells Exposed to Oxidative Stress Stimuli: Implications for Parkinson's Disease. | 2016 Oct |
1 |
| 5 |
26097894 | The roles of redox enzymes in Parkinson's disease: Focus on glutaredoxin. | 2015 |
2 |
| 6 |
25118928 | The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling. | 2014 Aug 14 |
1 |
| 7 |
23954870 | The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease. | 2013 Dec 10 |
1 |
| 8 |
24252804 | The role of oxidative stress in Parkinson's disease. | 2013 |
1 |
| 9 |
22639965 | Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein. | 2012 Aug |
1 |
| 10 |
21850687 | Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. | 2011 Dec |
2 |
| 11 |
20921534 | LRRK2 is involved in the IFN-gamma response and host response to pathogens. | 2010 Nov 1 |
1 |